| | | | | | | | The U.S. pharmaceuticals market is predicted to reach a volume of nearly $800 billion by 2028, with an annual growth rate of over 5%. However, dynamic developments outside of their control mean a mixed outlook for many pharmaceutical manufacturers as they navigate talent shortages, cybersecurity risks and cost pressures. To tackle these obstacles, it is important to understand what they are, how they are evolving, and what the industry can expect in 2024 and beyond. |
|
|
|
| |
| | |
|
|
| | | | | The oral granules can be sprinkled on food, providing a new administration option for those who have difficulty swallowing. |
|
|
| The agency wants your feedback on how to diversify perspectives and streamline committee processes. |
|
|
|
| |
| | |
|
|
| | | | Sponsored | | Upholding rigorous quality standards is not only a regulatory imperative but also vital for ensuring the efficacy and safety of pharmaceutical products. And as many pharma manufacturers have discovered, enhanced quality processes can also unlock significant performance improvements.But quality improvements... |
|
|
|
| |
| | |
|
|
| | |
|
| | |
|
